Dr. Suresh Challa
Overview
Suresh Challa is a primary care provider, practicing in Internal Medicine in Charlotte, North Carolina. Dr. Challa is rated as an Experienced provider by MediFind in the treatment of Thrombophlebitis. His top areas of expertise are Bile Duct Stricture, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Endoscopy. Dr. Challa is currently accepting new patients.
His clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1000 Blythe Blvd., Annex Bldg. 1st Floor, Charlotte, NC 28203
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Carolinas Medical Center
James Horton is a primary care provider, practicing in Internal Medicine in Charlotte, North Carolina. Dr. Horton is rated as an Advanced provider by MediFind in the treatment of Thrombophlebitis. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Horton is currently accepting new patients.
Harold Thomas is a primary care provider, practicing in Internal Medicine in Kannapolis, North Carolina. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Thrombophlebitis. His top areas of expertise are Sacroiliac Joint Disease, Peripheral Artery Disease, Maturity Onset Diabetes of the Young, and Type 2 Diabetes (T2D).
Carolinas Hospitalist Group At Atrium Health Mercy
Chandra Thondapi is a primary care provider, practicing in Internal Medicine in Charlotte, North Carolina. Dr. Thondapi is rated as an Experienced provider by MediFind in the treatment of Thrombophlebitis. His top areas of expertise are Necrosis, Sepsis, Acute Pancreatitis, Endoscopy, and Ureteroscopy. Dr. Thondapi is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Challa isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Bile Duct StrictureDr. Challa isAdvanced. Learn about Bile Duct Stricture.
- Lung CancerDr. Challa isAdvanced. Learn about Lung Cancer.
- Muscle Invasive Bladder CancerDr. Challa isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder Cancer
- Experienced
- Acute Kidney FailureDr. Challa isExperienced. Learn about Acute Kidney Failure.
- Acute Lymphoblastic Leukemia (ALL)Dr. Challa isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute PancreatitisDr. Challa isExperienced. Learn about Acute Pancreatitis.
- AgranulocytosisDr. Challa isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Challa isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.